A Structure‐Activity Relationship Study of Bimodal BODIPY‐Labeled PSMA‐Targeting Bioconjugates
Autor: | Caroline Hoffmann, Gregor Jung, Elmar Krause, Mark Bartholomae, Ina Hierlmeier, Stephan Maus, Tobias Stemler, Samer Ezziddin |
---|---|
Rok vydání: | 2021 |
Předmět: |
Glutamate Carboxypeptidase II
Male Cancer Research Fluorescence-lifetime imaging microscopy Peptidomimetic urologic and male genital diseases 01 natural sciences Biochemistry Cell membrane chemistry.chemical_compound Drug Discovery Fluorescence microscope General Pharmacology Toxicology and Pharmaceutics Internalization media_common Molecular Structure Full Paper Full Papers medicine.anatomical_structure Antigens Surface Molecular Medicine BODIPY Boron Compounds media_common.quotation_subject bimodal imaging Structure-Activity Relationship fluorescence imaging Very Important Paper LNCaP PSMA medicine Humans Structure–activity relationship Radiology Nuclear Medicine and imaging Pharmacology Dose-Response Relationship Drug 010405 organic chemistry Organic Chemistry Prostatic Neoplasms 0104 chemical sciences 010404 medicinal & biomolecular chemistry PET Microscopy Fluorescence chemistry Positron-Emission Tomography Biophysics Peptidomimetics Conjugate |
Zdroj: | Chemmedchem |
ISSN: | 1860-7187 1860-7179 |
Popis: | The aim of this study was to identify a high‐affinity BODIPY peptidomimetic that targets the prostate‐specific membrane antigen (PSMA) as a potential bimodal imaging probe for prostate cancer. For the structure‐activity study, several BODIPY (difluoroboron dipyrromethene) derivatives with varying spacers between the BODIPY dye and the PSMA Glu‐CO‐Lys binding motif were prepared. Corresponding affinities were determined by competitive binding assays in PSMA‐positive LNCaP cells. One compound was identified with comparable affinity (IC50=21.5±0.1 nM) to Glu‐CO‐Lys‐Ahx‐HBED‐CC (PSMA‐11) (IC50=18.4±0.2 nM). Radiolabeling was achieved by Lewis‐acid‐mediated 19F/18F exchange in moderate molar activities (∼0.7 MBq nmol−1) and high radiochemical purities (>99 %) with mean radiochemical yields of 20–30 %. Cell internalization of the 18F‐labeled high‐affinity conjugate was demonstrated in LNCaP cells showing gradual increasing PSMA‐mediated internalization over time. By fluorescence microscopy, localization of the high‐affinity BODIPY‐PSMA conjugate was found in the cell membrane at early time points and also in subcellular compartments at later time points. In summary, a high‐affinity BODIPY‐PSMA conjugate has been identified as a suitable candidate for the development of PSMA‐specific dual‐imaging agents. Have it both ways: By structure–activity relationship studies, a bimodal imaging probe combining fluorescence with nuclear imaging based on BODIPY dyes with high affinity for the prostate‐specific membrane antigen (PSMA) has been identified. The bimodal conjugate demonstrated PSMA‐specific uptake in prostate cancer cells with accumulation in the cell membrane at early time points and additional accumulation in subcellular compartments at later time points. |
Databáze: | OpenAIRE |
Externí odkaz: |